Hjortkloe Manufaktur

From BBReloaded
Revision as of 04:13, 21 August 2016 by Jhkloe (Talk | contribs)

Jump to: navigation, search
Hjortkloe Manufaktur
shh
HK M, Industrial Powerhouse.
Information
Type International Conglomerate
Industry Information & Medical Technology
Founded 1956, Västervik
Founder Konstantina Hjortkloe
Contemporary
Leadership

Greger Hjortkloe (President & CEO)

Jonas Hjortkloe (Board member & Company Heir)
Headquarters Progresse, New Västervik
Employees 14,800

Hjortkloe Manufaktur (English: Hjortkloe Manufactory) (Stylized as: HK M) is a technological & medicinal conglomerate with its roots in pre-war Sweden. HK M is driven forward by its founder's dynasty; Hjortkloe, with goals of rapid territorial as well as profitable expansion. As of current, Hjortkloe Manufaktur is under the leadership of Greger Hjortkloe, sitting CEO and Company President, and its board members.

Background of Hjortkloe Manufaktur

Beginnings & The Cold War Era (1956-1990)

During the early 1950's, a young Konstantina Hjortkloe, with her newly graduated team from Karolinska Instituted in Stockholm, consisting of doctors and physicians, were doing fieldwork and research in Korea, tending to wounded US soldiers and developing ways to fight off infections, tuberculosis and dysentery. Coming back to Sweden after the Korean War, Konstantina founded Hjortkloe Manufaktur in the town of Västervik, Northern Kalmar County. Using her experiences and research from the war, Konstantina were able to develop sophisticated vaccines that would protect people from the common ailments and infectious diseases. To the dismay and complaint of some of her colleagues, Konstantina decided to instead of issuing her results and medicines to the state, to patent her work and use it for profit.

From her institute in Västervik, Konstantina Hjortkloe made fortunes from selling large quantities of vaccines to states and private individuals wealthy enough for the treatment. As time passed, her patents went out of use and her work became open to public access. To facilitate income, Konstantina controversially left later batches of her vaccines functional, but incomplete, which left subjects vulnerable to new strains of old diseases. People that thought themselves as immune now turned back to Hjortkloe Manufaktur for aid. Some researchers, primarily from Karolinska Institutet went against patent law and did thorough research on Hjortkloe's vaccines and published criticizing articles in newspapers, condemning their old classmate for fraud. Whenever or not Konstantina had anything to do with the deed, two of the writers of the article were found dead in their apartments only days later after the papers were published.

Protected by her patents and because of the lack of an alternative, Konstantina continued her production of her vaccines to the international market, and flourished on new sprouting ailments as well as old ones.

Hjortkloe Manufaktur, Västervik, 1963

The Vietnam War brought new opportunities for Hjortkloe Manufaktur, and Konstantina sent out field teams to south east Asia to commence sabotage of medical equipment and spreading of harmful viruses under the false flag of aiding south Vietnamese hospitals and US field medics. The company grew to include hundreds of employees as world disease spread and countries turned to the reliable HK M for cures.

During the escalation of the situation in the space race, and the fall of the Berlin wall, scientists from either the USSR that fled from their Soviet Regime, or the US seeking protection from their corrupt officials, came to HK M asking Konstantina for refuge. With such new expertise, HK M took on new ambitions to create new technologies and machinery that only the crazy would dream of. As a consequence of this, the medicinal and vaccine branch of the company was put on a lower priority, and was after this only continued in secret.

Konstantina, at the age of 68, left the company in the hands of her daughter Alexandra Hjortkloe, who had during her years as a junior board member of the company made contacts all over the globe and had plans of her own for the expansion of the company.

Information Era & Work in the West (1991-2021)

Taking over the company, Alexandra Hjortkloe set sights on expanding the company into the IT market. HK M took significant steps for the development of computing units and early information sharing techniques. Working mostly behind closed doors, and withholding information about their work to the public, HK M shared projects with US Security and Surveillance services and institutes, such as the Central Intelligence Agency (CIA) and the National Security Agency (NSA), as to improve and develop new computing methods and security equipment.

Now taking part of international affairs, Hjortkloe Manufaktur grew to become one of Scandinavia's biggest political players as well as private research & development institutes.

Having produced parts of American warheads used conflicts in the middle east, to having their company name printed on US state funded security drones, HK M found themselves with a chip to play in the foreign and international security market.

IODS, NSM & The World at War (2022-2044)

Contemporary Hjortkloe Manufaktur

Leaving the Bunkers & Progresse (2044-2071)

Risk, Relief & Victory (2071-2121)

Expansion (2121-)

Board of Directors

Board of Directors (2144)
CEO & President Greger Hjortkloe
Company Heir Jonas Hjortkloe
Head of Information Veronica Harnítroca Déro
Head of Administration Madeleine af Säfwenquist
Head of Public Relations Toni Van Deijck
Head of Technology Alfred Au Månbåge
Head of Medicine & Biotech. George Folkesson
Division Chief of Medicine Hugo Folkesson
Member Henrietta Silvferpäls
Member Karl Filip Törnstedt
Member Estrid Gyllengrieph
Member Teresia Ehrenschöld

Industry

Faction & Company Relations